Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Positive Vascular Effect of Hesperidin in Subjects Affected by Metabolic Syndrome

NCT00914251 is registered in ClinicalTrials.gov with University of Rome Tor Vergata as lead sponsor.

NCT NCT00914251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00914251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Positive Vascular Effect of Hesperidin in Subjects Affected by Metabolic Syndrome
Lead sponsor
University of Rome Tor Vergata
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2008
Completion date
December 31, 2010
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endothelial dysfunction, metabolic syndrome